DOSSIER · 13F-HR · Q1 2026

GordonMD Global Investments LP

$144M in tracked AUM across 16 positions as of Q1 2026.

GG
CIK 0002039349 · last filed Mar 31, 2026
Total AUM
$144M
as of Q1 2026
Holdings
16
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

GordonMD Global Investments LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
KYTX
KYVERNA THERAPEUTICS INC
$37M4.2M25.5%
02
TSHA
TAYSHA GENE THERAPIES INC
$22M738K15.5%
03
VIR
VIR BIOTECHNOLOGY INC
$14M1.5M9.5%
04
BLCO
BAUSCH PLUS LOMB CORP
$9M573K6.3%
05
AMGN
AMGEN INC
$7M20K5.0%
06
SRRK
SCHOLAR ROCK HLDG CORP
$7M133K4.5%
07
RARE
ULTRAGENYX PHARMACEUTICAL IN
$6M289K4.2%
08
PYXS
PYXIS ONCOLOGY INC
$6M4.1M4.2%
09
TEVA
TEVA PHARMACEUTICAL INDS LTD
$6M1.3M3.9%
10
SION
SIONNA THERAPEUTICS INC
$5M136K3.8%

Filing history

2026Q1Mar 31
$144M 2.9%
16 positionsView →
2025Q4Dec 31
$139M
13 positionsView →